RNTX
Income statement / Annual
Last year (2024), Rein Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Rein Therapeutics Inc.'s net income was -$62.88 M.
See Rein Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$14,248.00
|
$3,991.00
|
$17,967.00
|
$17,008.00
|
$11,166.00
|
| General & Administrative Expenses |
$13.86 M
|
$11,357.00
|
$9,680.00
|
$9,597.00
|
$9,330.00
|
| Selling & Marketing Expenses |
-$13.85 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13,864.00
|
$11,357.00
|
$9,680.00
|
$9,597.00
|
$9,330.00
|
| Other Expenses |
$0.00
|
$928.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$65,111.00
|
$16,276.00
|
$27,647.00
|
$26,605.00
|
$20,496.00
|
| Cost And Expenses |
$65,111.00
|
$16,276.00
|
$27,647.00
|
$26,605.00
|
$20,496.00
|
| Interest Income |
$400,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$63,000.00
|
$119.00
|
$169.00
|
$121.00
|
$163.00
|
| EBITDA |
-$28.05 M |
-$15,229.00 |
-$27,478.00 |
-$26,484.00 |
-$20,333.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$800,000.00
|
$544.00
|
$318.00
|
$441.00
|
-$661.00
|
| Income Before Tax |
-$64.31 M
|
-$15,732.00
|
-$27,329.00
|
-$26,164.00
|
-$21,157.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.54 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$62.88 M
|
-$15,732.00
|
-$27,329.00
|
-$26,164.00
|
-$21,157.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.51 |
-3.42 |
-6.02 |
-5.89 |
-12.14 |
| EPS Diluted |
-3.51 |
-3.42 |
-6.02 |
-5.89 |
-12.14 |
| Weighted Average Shares Out |
$17,938.00
|
$4,598.00
|
$4,539.00
|
$4,440.00
|
$1,743.00
|
| Weighted Average Shares Out Diluted |
$17,938.00
|
$4,598.72
|
$4,539.32
|
$4,440.34
|
$1,743.34
|
| Link |
|
|
|
|
|
